Press release
Progressive Pulmonary Fibrosis Market Size in the 7MM was USD 1,300 Million in 2023, estimated DelveInsight
Discover Key Insights into the Progressive Pulmonary Fibrosis Market with DelveInsight's In-Depth Report @ Progressive Pulmonary Fibrosis Market Size [https://www.delveinsight.com/sample-request/progressive-pulmonary-fibrosis-ppf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Progressive Pulmonary Fibrosis Market Report
* In November 2024:- Bristol-Myers Squibb-A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis. The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.
* In November 2024:- Boehringer Ingelheim- A Phase IIa/IIb, Randomised, Double Blind, Placebo-controlled, Parallel-group Dose-finding Study to Examine the Efficacy and Safety of BI 1839100 Administered Orally Over a 12-week Treatment Period in Patients With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis With Clinically Meaningful Cough.
* In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of Progressive pulmonary fibrosis (PPF) in the 7MM were 135 thousand in 2023.
* The highest total diagnosed prevalent cases of Progressive pulmonary fibrosis (PPF) were accounted by the US in 2023 (77 thousand), which are expected to show a rise in the future.
* Among the European countries, Germany had the highest diagnosed prevalent cases of PPF with ~11 thousand cases, followed by the United Kingdom, which had prevalent population of 10 thousand in 2023. On the other hand, Spain had the lowest prevalent population (around 6 thousand cases).
* Japan had 10 thousand total diagnosed prevalent cases of Progressive pulmonary fibrosis (PPF) in 2023, accounting for approximately 8% in 7MM.
* The leading Progressive Pulmonary Fibrosis Companies such as Boehringer Ingelheim, Bristol-Myers Squibb , and others
* Promising Progressive Pulmonary Fibrosis Therapies such as BMS-986278, AP01, BI 1839100, BI 1015550, ENV-101, and others .
Stay ahead in the Progressive Pulmonary Fibrosis Therapeutics Market with DelveInsight's Strategic Report @ Progressive Pulmonary Fibrosis Market Outlook [https://www.delveinsight.com/sample-request/progressive-pulmonary-fibrosis-ppf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Progressive Pulmonary Fibrosis Epidemiology Segmentation in the 7MM
* Total Prevalent Cases of Interstitial Lung Disease
* Total Diagnosed Prevalent Cases of Interstitial Lung Disease
* Type-specific Diagnosed Prevalent Cases of Interstitial Lung Disease
* Total Diagnosed Prevalent Cases of Progressive pulmonary fibrosis
Download the report to understand which factors are driving Progressive Pulmonary Fibrosis epidemiology trends @ Progressive Pulmonary Fibrosis Prevalence [https://www.delveinsight.com/sample-request/progressive-pulmonary-fibrosis-ppf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Progressive pulmonary fibrosis Emerging Drugs
* Nerandomilast (BI 1015550): Boehringer Ingelheim
BI 1015550 is an investigational, oral, phosphodiesterase 4B (PDE4B) inhibitor with combined antifibrotic and anti-inflammatory effects being developed by Boehringer Ingelheim. It has the potential to address both pulmonary fibrosis - an irreversible scarring of lung tissue that negatively impacts lung function - and inflammation associated with Progressive pulmonary fibrosis (PPF) (ILDs). BI 1015550 represents the first molecule in the class of PDE4B inhibitors that is being studied for IPF and other progressive fibrosing ILDs.
Progressive pulmonary fibrosis Market Outlook
Progressive pulmonary fibrosis (PPF) consist of a diverse group of interstitial lung diseases (ILDs) characterized by a similar clinical phenotype of accelerated respiratory failure, frequent disease exacerbation and earlier mortality. ILD and its progressing forms, form a substantial proportion of disabling chronic lung disease leading to significant morbidity and mortality. From the current treatment market scenario, Nintedanib is the only approved treatment in the chronic fibrotic ILDs in the 7MM. Myriads of patients with PPFs are currently orphan of evidence-based treatments and are left with options of receiving corticosteroids and/or off-label immunosuppressive therapies with variable outcomes and are the mainstay of treatment in PPFs. These unmet treatment gaps accentuates the launch of emerging therapies.
Get In-Depth Knowledge on Progressive Pulmonary Fibrosis Market Trends and Forecasts with DelveInsight @ Progressive Pulmonary Fibrosis Treatment Market [https://www.delveinsight.com/sample-request/progressive-pulmonary-fibrosis-ppf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Progressive Pulmonary Fibrosis Market Report
* Coverage- 7MM
* Pulmonary Fibrosis Companies- Boehringer Ingelheim, Bristol-Myers Squibb, and others
* Progressive Pulmonary Fibrosis Therapies- BMS-986278, AP01, BI 1839100, BI 1015550, ENV-101, and others.
* Progressive Pulmonary Fibrosis Therapeutic Assessment: Progressive Pulmonary Fibrosis Current marketed and Lipodystrophy Emerging Therapies
* Progressive Pulmonary Fibrosis Market Dynamics: Progressive Pulmonary Fibrosis Market drivers and Lipodystrophy Market Barriers
Unlock Strategic Insights with DelveInsight's Comprehensive Progressive Pulmonary Fibrosis Market Report @ Progressive Pulmonary Fibrosis Market Drivers and Barriers [https://www.delveinsight.com/sample-request/progressive-pulmonary-fibrosis-ppf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1 Key Insights
2 Report Introduction
3 Progressive pulmonary fibrosis (PPF) Market Overview at a Glance
4 Methodology of Progressive pulmonary fibrosis (PPF) Epidemiology and Market
5 Executive Summary of Progressive pulmonary fibrosis (PPF)
6 Key Events
7 Disease Background and Overview
8 Epidemiology and Patient Population
9 Patient Journey
10 Marketed Therapies
11 Emerging Therapies
12 Progressive pulmonary fibrosis (PPF): Market Analysis
13 KOL Views
14 SWOT Analysis
15 Unmet needs
16 Market Access and Reimbursement
17 Appendix
18 DelveInsight Capabilities
19 Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=progressive-pulmonary-fibrosis-market-size-in-the-7mm-was-usd-1300-million-in-2023-estimated-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/in-licensing-opportunity
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Progressive Pulmonary Fibrosis Market Size in the 7MM was USD 1,300 Million in 2023, estimated DelveInsight here
News-ID: 3750273 • Views: …
More Releases from ABNewswire
Self Employed Tax Software UK: Why Freelancers and Sole Traders Are Switching to …
With Many individuals are seeking software that simplifies tax filing while ensuring full compliance with HMRC requirements. Manual spreadsheets and paper-based calculations are being replaced by real-time, automated systems that give users visibility over their tax position throughout the year. Among the platforms gaining traction is Pie, a UK-based digital tax app built specifically to support self-employed individuals with modern income needs.
LONDON, United Kingdom - February 19, 2026 - Demand…
CivicMail.org Reinvents Postcard Campaigns for Grassroots Advocacy
CivicMail.org aims to bring civic engagement back to basics through the power of pen, paper, and postage.
Image: https://www.abnewswire.com/upload/2026/02/2addd1e9e0381d7e2262e1edbb064123.jpg
CivicMail.org [https://civicmail.org/] has announced its launch to help Americans send real, physical postcards to their elected officials with just a few clicks, delivering personalized messages directly to the desks of decision-makers at the local, state, and federal levels.
Research shows [https://www.concordia.ca/news/stories/2021/09/24/personalized-messages-are-more-likely-to-get-a-response-from-politicians-new-research-finds.html] that physical mail carries more weight with elected officials than petitions, emails, or…
New Children's Story: The Story of Sharin' Bear
A Heartfelt Message Of Courage, Kindness, And The True Meaning Of Giving
A pleasant new story for children, The Story of Sharin' Bear by Sharon Woods , introduces families to a lovable little cub whose journey of bravery and compassion changes him into a representation of sharing for children globally.
Entrenched in adventure, innocence, and emotional growth, this uplifting tale offers an unforgettable reminder that even the smallest acts of kindness can…
Fast-Growing Newman's Brew Combines Organic Coffee Excellence with Abandoned Ani …
Newman's Brew is experiencing rapid expansion by delivering on dual commitments that resonate with today's conscious consumers: exceptional fresh-roasted organic coffee and meaningful support for abandoned animals. The company's growing inventory and ethical business practices demonstrate that quality and social responsibility can drive sustainable business success in the competitive specialty coffee market.
Newman's Brew is riding a wave of growth that reflects fundamental shifts in how consumers approach coffee purchasing decisions.…
More Releases for Progressive
Progressive Insurance Market Is Booming So Rapidly | Major Giants Progressive Co …
HTF MI just released the Global Progressive Insurance Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Progressive Corporation, State Farm, Allstate, GEICO,…
Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2024 - …
"The progressive multifocal leukoencephalopathy treatment market size has grown rapidly in recent years. It will grow from $1.31 billion in 2023 to $1.46 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to prevalence of underlying conditions, rise in immunosuppressed patients, patient advocacy and awareness, rise of hiv/aids epidemic.
The progressive multifocal leukoencephalopathy treatment market size is…
Progressive Multifocal Leukoencephalopathy Treatment Market Size 2034
DelveInsight's 'Progressive Multifocal Leukoencephalopathy Market Insights, Epidemiology, and Market Forecast - 2034' report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of Progressive Multifocal Leukoencephalopathy in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
Key Takeaways from the Progressive Multifocal Leukoencephalopathy Market Report
• According to DelveInsight's analysis, the incident cases of PML in the 7MM were approximately 4…
Seminar on Progressive Farming
Shri Venkateshwara University/VGI Meerut in collaboration with Bhartiya Kisan Union (Meerut Division) is organizing a 1 day seminar on Progressive farming & farmer the foundation of development on Nov 3rd.In this seminar, the National Organization Minister of All India Farmer's Organization Mr Dinesh Kulkarni, Padamshree Mr Bharat Bhushan Tyagi, & the State Agriculture Minister Mr Baldev Singh Aulakh will take part.Apart from these renowned agriculture scientists, environmentalists, bureaucrats & 400…
Progressive Supranuclear Palsy Headed Toward Cure
Progressive supranuclear palsy (PSP) is a brain disorder which impacts vision, cognition, movement, and speech. This disease results in weakness by affecting certain parts of the brain above the cell clusters, known as nuclei (supranuclear), which are involved in controlling eye movements. It usually manifests in mid-to late adulthood, and the survival rate of people suffering from PSP is five to nine years after the disease first appears. It is…
Progressive Personnel rebrands to Progressive Travel Recruitment
Global travel and hospitality recruitment leader, Progressive Personnel, this month re-emerges as Progressive Travel Recruitment with a fresh new look and a new website under the new URL – www.progressivetravelrecruitment.com – with enhanced job search capability.
Progressive Travel Recruitment’s competitive edge, however, remains – a dedicated team of specialist travel recruiters, who have themselves worked in the industry and understand intimately the needs of travel companies and travel candidates, and…
